Decibel Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Decibel Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2023.
  • Decibel Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$18.1M, a 6.45% decline year-over-year.
  • Decibel Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$63.4M, a 5.02% decline year-over-year.
  • Decibel Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$63M, a 21.6% decline from 2021.
  • Decibel Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$51.8M, a 31.7% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$63.4M -$18.1M -$1.1M -6.45% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 -$62.3M -$13.3M +$712K +5.08% Jan 1, 2023 Mar 31, 2023 10-Q 2023-08-11
Q4 2022 -$63M -$15.9M -$3.04M -23.5% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-14
Q3 2022 -$60M -$16M +$394K +2.4% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 -$60.4M -$17M -$5.4M -46.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$55M -$14M -$3.15M -28.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-11
Q4 2021 -$51.8M -$12.9M -$19K -0.15% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-14
Q3 2021 -$51.8M -$16.4M -$9.29M -131% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$42.5M -$11.7M -$3.84M -49.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-09
Q1 2021 -$38.7M -$10.9M +$665K +5.77% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-09
Q4 2020 -$39.3M -$12.9M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-18
Q3 2020 -$7.11M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$7.81M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$11.5M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.